Stifel lowered the firm’s price target on Inspire Medical (INSP) to $95 from $110 and keeps a Buy rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INSP:
- Inspire Medical price target lowered to $85 from $165 at Piper Sandler
- Inspire Medical price target lowered to $67 from $118 at JPMorgan
- Inspire Medical price target lowered to $85 from $130 at Mizuho
- Inspire Medical downgraded to Hold from Buy at Nephron Research
- Inspire Medical downgraded to Equal Weight from Overweight at Wells Fargo